Feature

Grid Battery Metals Inc. (OTCQB: EVKRF) is in the right sector with the right assets at the right time. And investors apparently agree. Since June, they have bid shares higher by over 124% to $0.08 on Wednesday, a slight retreat from 52-week highs set last month. However, profit-taking is to be expected, and the more important consideration for investors is the trend line trajectory that, with profit-taking aside, remains decidedly bullish. Plenty of reasons support EVKRF’s move higher. Foremost is

Investors wanting low-priced exposure in companies that are revolutionary to their sectors should waste no time learning about ASP Isotopes, Inc. (NasdaqCM: ASPI). More and more investors are beginning to heed that advice, and for good reasons. ASPI shares are higher by over 84% since July, even accounting for some light profit-taking on Friday. That surge is earned, in part, from an announcement in June highlighting a supply contract for a highly enriched isotope for a US customer worth approximately

Graphite One (TSXV: GPH | OTC: GPHOF) stock is higher by over 29% since the start of July. While impressive, that trend may continue. And for excellent reason. Foremost is that GPHOF just scored a massive value driver, an over $37 million investment grant from the Department of Defense (DoD) to “perform an accelerated Feasibility Study to modernize and expand domestic production capacity and supply for graphite battery anodes necessary for electronic vehicles and alternative energy batteries, as an essential national

Dragonfly Energy (NASDAQ: DFLI) shares may be priced at smallcap levels, but don’t be misled- this company is doing some crucial things to create a pathway for battery independence for the United States and potentially its allies. And that points to one thing: at $1.97 on Wednesday, its valuation ignores the most basic intrinsic values deserved. That’s appraising just what’s in its portfolio.  Factoring in the inherent value, especially related to how it positions Dragonfly Energy to contribute to an

RenovoRx, Inc. (NASDAQ: RNXT) shares are back in rally mode, rising over 13% since this week’s start. After consolidating at lower prices, the break higher can be attributed to RNXT announcing a positive update from its TIGeR-PaC trial. While profit-taking is to be expected, investor’s shouldn’t be fooled by the sell-the-news action. Data reported indicates that RNXT is now better positioned than ever to get a best-in-class, even front-line, treatment to market to battle pancreatic cancer. Moreover, the data supports investors

Like taking investment risk knowing there’s potential for exponential returns? How about buying a low-priced stock that provides solid exposure to the booming precious metals and digital assets sectors? If you check those boxes with a “yes,” Asia Broadband Inc. (OTC: AABB) is a company and stock to consider. Yes, there’s implied risk. But with a growing asset base to support an intrinsic valuation at higher levels, the rewards from catching this stock during weakness could yield significant near-term returns.